Beda Pharmaceuticals: The company has corresponding pre-clinical projects in the KRAS target area.

On July 19th, BeiDa Pharmaceutical stated on the interactive platform that the company has corresponding pre-clinical projects approved at the KRAS target point. Currently, the team is intensifying efforts to advance and submit clinical trial applications as soon as possible.